The results indicate that HuR specifically affects T cells and the Wingless Int-1 (WNT) signaling pathway in HNSCC and regulates immunological functions, making it a potential treatment option for HNSCC cases with HuR overexpression [12]. The gene discussed is ELAVL1; the disease is head and neck squamous cell carcinoma.